{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéine p120 d'activation de la ras GTPase : Questions médicales les plus fréquentes",
"headline": "Protéine p120 d'activation de la ras GTPase : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéine p120 d'activation de la ras GTPase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-16",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéine p120 d'activation de la ras GTPase"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines d'activation de la ras GTPase",
"url": "https://questionsmedicales.fr/mesh/D020703",
"about": {
"@type": "MedicalCondition",
"name": "Protéines d'activation de la ras GTPase",
"code": {
"@type": "MedicalCode",
"code": "D020703",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.325.150.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéine p120 d'activation de la ras GTPase",
"alternateName": "p120 GTPase Activating Protein",
"code": {
"@type": "MedicalCode",
"code": "D020729",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "René Rasche",
"url": "https://questionsmedicales.fr/author/Ren%C3%A9%20Rasche",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biochemistry, University Münster, Germany."
}
},
{
"@type": "Person",
"name": "Daniel Kümmel",
"url": "https://questionsmedicales.fr/author/Daniel%20K%C3%BCmmel",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biochemistry, University Münster, Germany."
}
},
{
"@type": "Person",
"name": "Manil Kanade",
"url": "https://questionsmedicales.fr/author/Manil%20Kanade",
"affiliation": {
"@type": "Organization",
"name": "Indian Institute of Science Education and Research, Pune, India."
}
},
{
"@type": "Person",
"name": "Pananghat Gayathri",
"url": "https://questionsmedicales.fr/author/Pananghat%20Gayathri",
"affiliation": {
"@type": "Organization",
"name": "Indian Institute of Science Education and Research, Pune, India."
}
},
{
"@type": "Person",
"name": "Qingqing Dai",
"url": "https://questionsmedicales.fr/author/Qingqing%20Dai",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine IV (Gastroenterology, Hepatology, and Infectious Diseases), Jena University Hospital, Jena, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Conscious cognitive effort in cognitive control.",
"datePublished": "2022-10-20",
"url": "https://questionsmedicales.fr/article/36263671",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/wcs.1629"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Seizure Control With Cognition in People With Normal Cognition and Mild Cognitive Impairment.",
"datePublished": "2024-08-22",
"url": "https://questionsmedicales.fr/article/39173101",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1212/WNL.0000000000209820"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Cognitive Polygenic Index and Cognitive Performance with Age in Cognitively Healthy Adults.",
"datePublished": "2023-09-18",
"url": "https://questionsmedicales.fr/article/37761954",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/genes14091814"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognition.",
"datePublished": "2023-03-22",
"url": "https://questionsmedicales.fr/article/36948175",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000527939"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computerized cognitive games versus cognitive exergame: the comparison of motor and cognitive functions enhancement in the elderly.",
"datePublished": "2024-10-11",
"url": "https://questionsmedicales.fr/article/39394166",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40359-024-02064-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Régulateurs des protéines G",
"item": "https://questionsmedicales.fr/mesh/D020555"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines d'activation de la GTPase",
"item": "https://questionsmedicales.fr/mesh/D020690"
},
{
"@type": "ListItem",
"position": 7,
"name": "Protéines d'activation de la ras GTPase",
"item": "https://questionsmedicales.fr/mesh/D020703"
},
{
"@type": "ListItem",
"position": 8,
"name": "Protéine p120 d'activation de la ras GTPase",
"item": "https://questionsmedicales.fr/mesh/D020729"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéine p120 d'activation de la ras GTPase - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéine p120 d'activation de la ras GTPase",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéine p120 d'activation de la ras GTPase",
"description": "Comment diagnostiquer une anomalie de p120 GTPase ?\nQuels tests sont utilisés pour évaluer p120 GTPase ?\nY a-t-il des biomarqueurs associés à p120 GTPase ?\nQuels symptômes peuvent indiquer un problème avec p120 ?\nComment les mutations de p120 sont-elles détectées ?",
"url": "https://questionsmedicales.fr/mesh/D020729?mesh_terms=Cognition#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéine p120 d'activation de la ras GTPase",
"description": "Quels symptômes sont liés à une dysfonction de p120 GTPase ?\nLa dysfonction de p120 peut-elle causer des cancers ?\nQuels types de cancers sont liés à p120 GTPase ?\nY a-t-il des signes précoces de dysfonction de p120 ?\nComment p120 affecte-t-il la signalisation cellulaire ?",
"url": "https://questionsmedicales.fr/mesh/D020729?mesh_terms=Cognition#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéine p120 d'activation de la ras GTPase",
"description": "Peut-on prévenir les mutations de p120 ?\nY a-t-il des mesures préventives pour le cancer lié à p120 ?\nComment l'alimentation influence-t-elle p120 ?\nLe tabagisme affecte-t-il p120 GTPase ?\nL'exercice physique peut-il aider à prévenir les cancers ?",
"url": "https://questionsmedicales.fr/mesh/D020729?mesh_terms=Cognition#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéine p120 d'activation de la ras GTPase",
"description": "Quels traitements ciblent p120 GTPase ?\nPeut-on utiliser des médicaments pour moduler p120 ?\nY a-t-il des essais cliniques pour p120 ?\nComment la thérapie génique peut-elle aider ?\nQuels sont les effets secondaires des traitements ciblés ?",
"url": "https://questionsmedicales.fr/mesh/D020729?mesh_terms=Cognition#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéine p120 d'activation de la ras GTPase",
"description": "Quelles complications peuvent survenir avec p120 ?\nComment p120 affecte-t-il le pronostic du cancer ?\nY a-t-il des complications liées aux traitements de p120 ?\nLes mutations de p120 augmentent-elles le risque de récidive ?\nQuelles sont les implications des anomalies de p120 ?",
"url": "https://questionsmedicales.fr/mesh/D020729?mesh_terms=Cognition#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéine p120 d'activation de la ras GTPase",
"description": "Quels sont les facteurs de risque pour les mutations de p120 ?\nL'âge est-il un facteur de risque pour p120 ?\nLes antécédents familiaux influencent-ils p120 ?\nLe stress peut-il affecter p120 GTPase ?\nY a-t-il des expositions environnementales à surveiller ?",
"url": "https://questionsmedicales.fr/mesh/D020729?mesh_terms=Cognition#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie de p120 GTPase ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses protéomiques peuvent être utilisés pour diagnostiquer."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer p120 GTPase ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'immunoblotting et la PCR pour détecter les mutations."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés à p120 GTPase ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de p120 peuvent servir de biomarqueurs dans certaines pathologies."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec p120 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de croissance cellulaire ou des cancers peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Comment les mutations de p120 sont-elles détectées ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations peuvent être détectées par séquençage génétique et analyses fonctionnelles."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysfonction de p120 GTPase ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des troubles de croissance et des anomalies cellulaires."
}
},
{
"@type": "Question",
"name": "La dysfonction de p120 peut-elle causer des cancers ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations dans p120 sont associées à divers types de cancers."
}
},
{
"@type": "Question",
"name": "Quels types de cancers sont liés à p120 GTPase ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cancers comme le cancer du poumon et le mélanome sont souvent associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes précoces de dysfonction de p120 ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes précoces peuvent inclure des anomalies dans le développement cellulaire."
}
},
{
"@type": "Question",
"name": "Comment p120 affecte-t-il la signalisation cellulaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "p120 régule la signalisation en activant les GTPases, influençant la prolifération."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les mutations de p120 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention des mutations est difficile, mais un mode de vie sain peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour le cancer lié à p120 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dépistages réguliers et un mode de vie sain peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle p120 ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut influencer la santé cellulaire et réduire les risques."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il p120 GTPase ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter le risque de mutations et de cancers associés."
}
},
{
"@type": "Question",
"name": "L'exercice physique peut-il aider à prévenir les cancers ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier est associé à une réduction du risque de certains cancers."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent p120 GTPase ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des inhibiteurs spécifiques sont en développement."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des médicaments pour moduler p120 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent moduler l'activité de p120 dans les cellules."
}
},
{
"@type": "Question",
"name": "Y a-t-il des essais cliniques pour p120 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des essais cliniques évaluent des traitements ciblant les anomalies de p120."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique peut-elle aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique pourrait corriger les mutations de p120 dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ciblés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des réactions immunitaires et des toxicités cellulaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec p120 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des cancers avancés et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Comment p120 affecte-t-il le pronostic du cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies de p120 peuvent aggraver le pronostic et la réponse au traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications liées aux traitements de p120 ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications comme des effets secondaires graves peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les mutations de p120 augmentent-elles le risque de récidive ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les mutations peuvent augmenter le risque de récidive du cancer après traitement."
}
},
{
"@type": "Question",
"name": "Quelles sont les implications des anomalies de p120 ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies de p120 peuvent entraîner des troubles de croissance et des cancers."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les mutations de p120 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour p120 ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de mutations et de cancers associés augmente avec l'âge."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils p120 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer peuvent augmenter le risque de mutations."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter p120 GTPase ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut influencer la régulation de p120 et augmenter les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des expositions environnementales à surveiller ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des agents cancérigènes peut augmenter le risque de mutations."
}
}
]
}
]
}
Division of Nephrology, McGill University Health Centre, Montreal, Quebec, Canada; Research Institute, McGill University Health Centre, Montreal, Quebec, Canada.
Publications dans "Protéine p120 d'activation de la ras GTPase" :
Division of Nephrology, McGill University Health Centre, Montreal, Quebec, Canada; Research Institute, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: tomoko.takano@mcgill.ca.
Publications dans "Protéine p120 d'activation de la ras GTPase" :
Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Environment and Bio-Resource of the Three Gorges Area, Key Laboratory of Eco-Environments in Three Gorges Reservoir Region, Ministry of Education, School of Life Sciences, Southwest University, Chongqing, China.
Publications dans "Protéine p120 d'activation de la ras GTPase" :
Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Environment and Bio-Resource of the Three Gorges Area, Key Laboratory of Eco-Environments in Three Gorges Reservoir Region, Ministry of Education, School of Life Sciences, Southwest University, Chongqing, China.
Publications dans "Protéine p120 d'activation de la ras GTPase" :
Cognitive effort is thought to be familiar in everyday life, ubiquitous across multiple variations of task and circumstance, and integral to cost/benefit computations that are themselves central to th...
Seizures are common in dementia and associated with accelerated cognitive decline. However, the impact of active vs remote seizures on cognition remains understudied. This study aimed to investigate t...
This longitudinal, multicenter cohort is based on National Alzheimer's Coordinating Center data of participants recruited from 39 Alzheimer's Disease Centers in the United States from September 2005 t...
Of the 13,726 participants with normal cognition at enrollment (9,002 [66%] female; median age 71 years), 118 had active seizures and 226 had remote seizures. Of the 11,372 participants with MCI at en...
In this study, active seizures but not remote seizures were associated with earlier cognitive decline in both cognitively normal adults and those with MCI, independent of other dementia risk factors. ...
Genome-wide association studies have discovered common genetic variants associated with cognitive performance. Polygenic scores that summarize these discoveries explain up to 10% of the variance in co...
Considering the importance of cognitive and motor functions of the elderly people, the present study was conducted to evaluate the effectiveness of a cognitive exergame, called Neurolight compared to ...
A total of 36 individuals in the age range of 60 to 69 years were studied in the form of three groups: The control group continued their daily activities, while the Neurolight group underwent a cognit...
The results showed that cognitive-motor exercises using Neurolight, for 24 sessions, were able to significantly improve working memory, inhibitory control, and balance in individuals in this age group...
This finding supports the other studies suggesting combined cognitive and physical exercises for better effect. Based on its findings, the use of this exercise system can be suggested to coaches and t...
When making decisions, humans aim to maximize rewards while minimizing costs. The exertion of mental or physical effort has been proposed to be one those costs, translating into avoidance of behaviors...
The evaluation of cognitive functions interactions has become increasingly implemented in the cognition exploration. In the present study, we propose to examine the organization of the cognitive netwo...
In this editorial, the editors briefly introduce the aims of the Special Issue. If the goal of the scientific field of Cognitive Psychology is to improve our understanding of human cognition, then res...
The present article provides a unified systematic account of the role of cognitive control, motivation and dopamine pathways in relation to the development of fatigue. Since cognitive fatigue is consi...
Debate continues regarding the use of self- versus informant-report to diagnose mild cognitive impairment (MCI) with studies reporting patients both overestimating and underestimating their abilities ...
Three hundred six participants with MCI, and their informants, reported on cognitive decline; the participants also completed a comprehensive assessment of objective cognitive and functional performan...
Informant- but not self-reported cognitive decline significantly correlated with objective cognitive performance. There were 68 underestimators, 94 congruent estimators, and 144 overestimators. Undere...
We showed a poor concordance among self-report of cognitive decline and both informant-report of cognitive decline and cognitive performance in patients with MCI. Our findings highlight clinical and r...